by the palm oil price situation in the country which remains low. Moreover, the domestic production capacity increased by 1.20 million litres per day from the same period of the previous year, led to
PTA margins, while Fibers business remains impacted by negative raw material price lag. Production increased 9% to 9.9 million tons, with contribution from M&A and projects while overall operating
driver supporting the Thai economy. However, tourism sector remains highly contracted for the second consecutive quarter due to no entry of foreign tourists during international travel restrictions of
rights and obligations of warrant issuer and warrantholders in relation to FVC-W1) (2) the number of 1,753 shares at the par value of Baht 0.50, which remains unissued, due to rounding down of fraction of
therefore emissions of different building types. This approach is referred to as Condition 1. Condition 1, while inherently simplistic, still remains out of reach for some cities and for some building types
in PTA and PET have been successfully turned around and have added significant earnings to 2019. This is also the case with the assets acquired in the Fibers segment, most of which are contributing
underperforming assets added through M&A in PTA and PET have been successfully turned around and have added significant earnings to 2019. This is also the case with the assets acquired in the Fibers segment, most
previous expected growth of 2.8% to be at -5.3%. Foreign investors continued net sales in the 8-month period of around Baht 2.2 billion, but institutional investors turned to be net buyers for the first time
challenging factors for future performance in 2020 whether the economic volatility and other challenges, which shall impact the Company's performance. The management, therefore, remains committed to the
Public Company Limited Future operating trends The Company remains committed to maintaining its leadership in the healthcare industry by focusing on the development of quality, efficiency, and responding